Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JP Morgan Reinstates Underweight on Intel, Lowers Price Target to $32

JP Morgan analyst Harlan Sur reinstates Intel (NASDAQ:INTC) with a Underweight and lowers the price target from $64 to $32.

byBenzinga Newsdesk

November 11, 2022

1 minute read

JP Morgan analyst Harlan Sur reinstates Intel (NASDAQ:INTC) with a Underweight and lowers the price target from $64 to $32.

Traeger Q1 EPS $0.17 Beats $0.09 Estimate, Sales $223.70M Beat $210.10M Estimate

By Michael Horton

Today, 5:12 AM

Traeger (NYSE:COOK) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.09 by 88.89 percent. The company reported quarterly sales of $223.70 million which beat the analyst

COOK

Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 15

By Akanksha Bakshi

Today, 5:12 AM

CNBC China's Fintech Specialist Sees Digital Yuan Challenging US Dollar

GOOG

News

Mirati Therapeutics Clinical Research at ESMO Congress 2021 to Highlight Progress with Investigational Adagrasib and Sitravatinib in Patients with Lung and Colorectal Cancers

By Benzinga Newsdesk

Today, 5:12 AM

Mirati Therapeutics, Inc. (NASDAQ:MRTX), a clinical-stage targeted oncology company, today announced two oral presentations of clinical data will be presented at the upcoming European Society for Medical Oncology

MRTX